Coping with a lack of evidence: living-donor kidney transplantation in the initial phase of the SARS-CoV-2 pandemic

Due to immunosuppressive therapy, transplant patients are more susceptible to viral and bacterial infections. A potentially deadly new virus haunted us in 2020: SARS-CoV‑2, causing coronavirus disease 19 (COVID-19). We analyzed the consequences of this previously unknown risk for our living-donor tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Nadina, Rösch, Christiane Sophie, Krause, Axel, Kalteis, Manfred, Enkner, Wolfgang, Haller, Maria, Cejka, Daniel, Függer, Reinhold, Biebl, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562069/
https://www.ncbi.nlm.nih.gov/pubmed/36258696
http://dx.doi.org/10.1007/s10353-022-00781-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562069/
https://www.ncbi.nlm.nih.gov/pubmed/36258696
http://dx.doi.org/10.1007/s10353-022-00781-9

Ejemplares similares